NANO Nuclear Energy Inc. announced that the U.S. Nuclear Regulatory Commission (NRC) has updated its project landing page to officially designate NANO Nuclear as the designer of the KRONOS MMRTM ...
MYC amplification found in approximately 30% of solid tumors Phase 1/2 clinical trial to begin in the first quarter of 2021 KB-0742 generated using the company’s proprietary small molecule microarray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback